Open AccessRethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring
Author(s) -
Wafa Habbal,
Fawza Monem
Publication year - 2012
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.2596
Subject(s) - hepatitis b virus , genotype , genotyping , drug resistance , virology , hepatitis b , medicine , interferon , immunology , virus , biology , gene , genetics
Hepatitis B virus patients are usually treated in Syria with alpha interferon and nucleos(t)ide analogues. Genotypic viral factors causing inadequate response or relapse following initial response are not routinely investigated. This study aimed to explore and discuss local therapeutic decisions from a molecular perspective.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom